Brian Sumner, MD

Residency: Mount Sinai Morningside - West
Medical school: George Washington University School of Medicine and Health Sciences

Post-resuscitation shock occurs in 50-70% of patients after out-of-hospital cardiac arrest, and this study provides evidence that norepinephrine is likely a preferable vasopressor to epinephrine in po
Few patients who suffer cardiac arrest from massive pulmonary embolism will survive to hospital discharge. From the evidence available, there is no clear mortality or functional outcome benefit to any
One study showed short-term benefit to using vasopressin and methylprednisolone in patients who experience in-hospital cardiac arrest. But study limitations mean further examination is needed before a
Anaphylaxis is a severe life-threatening acute systemic type 1 hypersensitivity reaction. This IgE-mediated reaction leads to varying degrees of mast-cell degranulation, histamine release and varying
Managing critically ill patients with cardiogenic shock often includes a decision between two inotropes: dobutamine and milrinone. Is there evidence to inform that choice?
What's the feasibility and safety of giving a high-dose nitroglycerin bolus for sympathetic crashing acute pulmonary edema?
This EMRA Critical Care Committee Deep Dive will review the current available literature on targeted temperature management for cardiac arrest.
Early fluid resuscitation has been proven to be a fundamental component in improving survival for patients with severe sepsis or septic shock. But what happens when a patient has cirrhosis?
Evidence surrounding the benefits of post-arrest hypothermia has been conflicting, but it continues to be the standard of care per international guidelines. The TTM2 Trial adds to the data.
As the coronavirus continues to mutate, researchers are examining every treatment option. This study looks at the efficacy of convalescent plasma for patients admitted to the hospital with COVID-19.
CHAT NOW
CHAT OFFLINE